{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:26:46Z","timestamp":1787030806500,"version":"build-2736575974"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Left-sided heart disease is the leading cause of pulmonary hypertension (PH). Right heart catheterization (RHC) is the gold standard for diagnosing PH, although it is invasive. Noninvasive cardiopulmonary exercise testing (CPET) could potentially help select heart failure (HF) patients who require RHC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The study aimed to assess whether CPET could predict PH in patients with HF.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>In this prospective cohort study, we analyzed data from 428 HF patients with a median age of 55 years and reduced left ventricular ejection fraction (\u226440%) who underwent both RHC and CPET. Patients with acute clinical instability or precapillary PH were excluded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The median LVEF was 20%, and 66.8% of patients were in NYHA class III or IV. PH was diagnosed by RHC in 76.9% of patients. Breathing reserve was lower and peak respiratory exchange ratio was higher in patients with PH. Patients with pulmonary vascular resistance (PVR)\u2009&amp;gt;\u20093 WU and mean pulmonary artery pressure &amp;gt;40 mmHg had lower indexed peak oxygen uptake and higher VE\/VCO2. Indexed peak oxygen uptake improved the prediction of PH with PVR\u2009&amp;gt;\u20093 WU when added to the model composed of clinical and laboratory parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No differences were observed in indexed peak oxygen uptake or VE\/VCO\u2082 slope between patients with and without PH. However, CPET results allowed more accurate prediction of more severe PH phenotypes. Patients with PH had lower ejection fraction and worse NYHA functional class and were more likely to be male and to have chronic kidney disease and diabetes. Overall, CPET parameters correlated with RHC findings and may help identify HF patients with PH, especially with high pulmonary vascular resistance. However, CPET cannot replace invasive hemodynamic assessment by RHC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1812393","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:45Z","timestamp":1787027325000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Relationship between right heart catheterization and exercise testing in heart failure patients with and without pulmonary hypertension \u2013 cross-sectional study"],"prefix":"10.3389","volume":"13","author":[{"given":"Filip","family":"Sawczak","sequence":"first","affiliation":[{"name":"College of Medical Sciences, SGMK Copernicus University","place":["Olsztyn, Poland"]},{"name":"1st Department of Cardiology, Poznan University of Medical Sciences","place":["Poznan, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Kukfisz","sequence":"additional","affiliation":[{"name":"3rd Department of Cardiology, Silesian Center for Heart Diseases, Medical University of Silesia","place":["Zabrze, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Dudek","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Poznan University of Medical Sciences","place":["Poznan, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Straburzy\u0144ska-Migaj","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Poznan University of Medical Sciences","place":["Poznan, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Ka\u0142u\u017cna-Oleksy","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Poznan University of Medical Sciences","place":["Poznan, Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ejhf.2333","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). with the special contribution of the heart failure association (HFA) of the ESC","volume":"24","author":"McDonagh","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"B2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S0735-1097(00)01102-5","article-title":"Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure","volume":"37","author":"Ghio","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.healun.2006.06.015","article-title":"Prognostic implications of serial assessments of pulmonary hypertension in severe chronic heart failure","volume":"25","author":"Grigioni","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/j.healun.2024.05.010","article-title":"International society for heart and lung transplantation guidelines for the evaluation and care of cardiac transplant candidates-2024","volume":"43","author":"Peled","year":"2024","journal-title":"J Heart Lung Transplant Off Publ Int Soc Heart Transplant"},{"key":"B7","first-page":"191","article-title":"Bleeding complications related to right heart catheterization in the setting of elevated INR","volume":"30","author":"Betz","year":"2018","journal-title":"J Invasive Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12931-021-01895-6","article-title":"Practical guide to cardiopulmonary exercise testing in adults","volume":"23","author":"Glaab","year":"2022","journal-title":"Respir Res"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1253\/circj.CJ-22-0032","article-title":"New conversion formula between B-type natriuretic peptide and N-terminal-pro-B-type natriuretic peptide- analysis from a multicenter study","volume":"86","author":"Ishihara","year":"2022","journal-title":"Circ J"},{"key":"B10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.21037\/atm-21-366","article-title":"The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease","volume":"9","author":"Zhong","year":"2021","journal-title":"Ann Transl Med"},{"key":"B11","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cardfail.2017.07.397","article-title":"Clinical and hemodynamic correlates and prognostic value of VE\/VCO2 slope in patients with heart failure with preserved ejection fraction and pulmonary hypertension","volume":"23","author":"Klaassen","year":"2017","journal-title":"J Card Fail"},{"key":"B12","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/ehf2.13726","article-title":"Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure","volume":"9","author":"Legris","year":"2022","journal-title":"ESC Heart Fail"},{"key":"B13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1378\/chest.10-0318","article-title":"Ventilatory inefficiency reflects right ventricular dysfunction in systolic heart failure","volume":"139","author":"Methvin","year":"2011","journal-title":"Chest"},{"key":"B14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jtcvs.2010.05.042","article-title":"Regression of \u201cfixed\u201d pulmonary vascular resistance in heart transplant candidates after unloading with ventricular assist devices","volume":"140","author":"Beyersdorf","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"79","author":"Heidenreich","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/ejhf.979","article-title":"Role of cardiopulmonary exercise testing in clinical stratification in heart failure. A position paper from the committee on exercise physiology and training of the heart failure association of the European Society of Cardiology","volume":"20","author":"Corr\u00e0","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e006000","DOI":"10.1161\/JAHA.117.006000","article-title":"Prognostic value of cardiopulmonary exercise testing in heart failure with reduced, midrange, and preserved ejection fraction","volume":"6","author":"Nadruz","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.ahj.2010.08.037","article-title":"Prediction of severe cardiovascular events by VE\/VCO2 slope versus peak VO2 in systolic heart failure: a meta-analysis of the published literature","volume":"160","author":"Poggio","year":"2010","journal-title":"Am Heart J"},{"key":"B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2174\/1874192401004010127","article-title":"Cardiopulmonary exercise testing in patients with chronic heart failure: prognostic comparison from peak VO2 and VE\/VCO2 slope","volume":"4","author":"Sarullo","year":"2010","journal-title":"Open Cardiovasc Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.21037\/jtd-20-1061b","article-title":"The value of cardiopulmonary exercise testing in the diagnosis of pulmonary hypertension","volume":"13","author":"Luo","year":"2021","journal-title":"J Thorac Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/eci.12851","article-title":"Cardiopulmonary exercise test predicts right heart catheterization","volume":"47","author":"Correale","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"B22","doi-asserted-by":"publisher","first-page":"100513","DOI":"10.1016\/j.ijcha.2020.100513","article-title":"Ventilatory power, a cardiopulmonary exercise testing parameter for the prediction of pulmonary hypertension at right heart catheterization","volume":"28","author":"Correale","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.advms.2016.06.001","article-title":"The strengths and weaknesses of non-invasive parameters obtained by echocardiography and cardiopulmonary exercise testing in comparison with the hemodynamic assessment by the right heart catheterization in patients with pulmonary hypertension","volume":"62","author":"Ptaszy\u0144ska-Kopczy\u0144ska","year":"2017","journal-title":"Adv Med Sci"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e12044","DOI":"10.1002\/pul2.12044","article-title":"Role of cardiopulmonary exercise test in the prediction of hemodynamic impairment in patients with pulmonary arterial hypertension","volume":"12","author":"Pezzuto","year":"2022","journal-title":"Pulm Circ"},{"key":"B25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/clc.22635","article-title":"Cardiopulmonary exercise testing improves diagnostic specificity in patients with echocardiography-suspected pulmonary hypertension","volume":"40","author":"Zhao","year":"2016","journal-title":"Clin Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2102548","DOI":"10.1183\/13993003.02548-2021","article-title":"Echocardiographic probability of pulmonary hypertension: a validation study","volume":"60","author":"D'Alto","year":"2022","journal-title":"Eur Respir J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.1093\/eurheartj\/ehaf194","article-title":"2025 ESC\/EACTS guidelines for the management of valvular heart disease: developed by the task force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European association for cardio-thoracic surgery (EACTS)","volume":"46","author":"Praz","year":"2025","journal-title":"Eur Heart J"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart disease and stroke statistics-2021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1136\/heartjnl-2021-320696","article-title":"Evaluation of the causes of sex disparity in heart failure trials","volume":"108","author":"Morgan","year":"2022","journal-title":"Heart Br Card Soc"},{"key":"B30","doi-asserted-by":"publisher","first-page":"100093","DOI":"10.1016\/j.ahjo.2022.100093","article-title":"Representation of women in heart failure clinical trials: barriers to enrollment and strategies to close the gap","volume":"13","author":"Reza","year":"2022","journal-title":"Am Heart J Plus Cardiol Res Pract"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1812393\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:28:46Z","timestamp":1787027326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1812393\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,18]]},"references-count":30,"alternative-id":["10.3389\/fcvm.2026.1812393"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1812393","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,18]]},"article-number":"1812393"}}